APA aipamena

Matsuoka, T., Yoshimatsu, G., Sakata, N., Kawakami, R., Tanaka, T., Yamada, T., . . . Kodama, S. (2020). Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death. Sci Rep.

Chicago Style aipamena

Matsuoka, Taisuke, Gumpei Yoshimatsu, Naoaki Sakata, Ryo Kawakami, Tomoko Tanaka, Teppei Yamada, Yoichiro Yoshida, Suguru Hasegawa, and Shohta Kodama. "Inhibition of NLRP3 Inflammasome By MCC950 Improves the Metabolic Outcome of Islet Transplantation By Suppressing IL-1β and Islet Cellular Death." Sci Rep 2020.

MLA aipamena

Matsuoka, Taisuke, et al. "Inhibition of NLRP3 Inflammasome By MCC950 Improves the Metabolic Outcome of Islet Transplantation By Suppressing IL-1β and Islet Cellular Death." Sci Rep 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.